PSMA Imaging as a Biomarker for Early Stage Prostate Cancer

PSMA Imaging Current Status and Prospects | SNMMI Annual Meeting 2020 | Telix PharmaceuticalsПодробнее

Finding Early-Stage Prostate Cancer with a PSMA PET ScanПодробнее

PSMA in Metastatic Prostate Cancer: Imaging as BiomarkerПодробнее

PSMA & Newly-Diagnosed #ProstateCancer | MarkScholzMD #AlexScholz #PCRIПодробнее

Biomarkers and Imaging in Upfront Metastatic Prostate Cancer DiagnosisПодробнее

How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRIПодробнее

PSA limitations in prostate cancer: advancing treatment de-escalation with imaging biomarkersПодробнее

PET Imaging for Prostate CancerПодробнее

Guidelines for using PSMA PET in the staging of prostate cancerПодробнее

Dr. Amar Kishan Discusses the Impact of Precision Medicine & PSMA Imaging in Prostate CancerПодробнее

2021: PSMA and Prostate Imaging | Dr. Thomas Hope | 2021 Moyad + Scholz Mid-Year Update | PCRIПодробнее

Dr. Morris on Next Steps for PSMA–Targeted PET Imaging in Prostate CancerПодробнее

Understanding PSMA/PET, Axumin, MRI, Ultrasound | Ask a Prostate Expert, Mark Scholz, MDПодробнее

PSMA PET Imaging - Summit 2021Подробнее

Prospective monitoring of patients with recurrent prostate cancer using serial PSMA imagingПодробнее

Biomarkers and Molecular Imaging for Prostate CancerПодробнее

PSMA Imaging & the Potential Role of PSMA Radioguided Surgery | Robert Reiter, MD, MBA | UCLA HealthПодробнее

Molecular Imaging of Prostate CancerПодробнее

PSMA/PET Scans: FDA Approved | Ask A Prostate Expert, Mark Scholz, MDПодробнее

PSMA PET-CT scan and treatments for patients with cN1 prostate cancerПодробнее